Home / Companies / Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited / 30 May 2024
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited: meeting of 30 May 2024
Votes reported on Form N-PX, item by item
39 Form N-PX filers reported votes at the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited meeting of 30 May 2024. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
11 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
7 vote records from 5 filers. 1 of the 5 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
418 vote records from 39 filers. 0 of the 38 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,190 vote records from 39 filers. 0 of the 38 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
978 vote records from 39 filers. 32 of the 38 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
75 vote records from 5 filers. 0 of the 5 filers that marked the item either way voted against management.
CORPORATE GOVERNANCESecurity holder
Shareholder proposal: CORPORATE GOVERNANCE
151 vote records from 33 filers. 0 of the 32 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Auditor | 7. Proposal |
|---|---|---|
| Vanguard | No report | For |
| BlackRock and iShares | No report | For |
| Fidelity | No report | For |
| Dimensional | No report | For |
| State Street and SPDR | No report | For |
| Franklin Templeton | No report | For |
| Charles Schwab | For | No report |
| Nuveen and TIAA | No report | For |
| John Hancock and Manulife | For | No report |
| Morgan Stanley, Eaton Vance and Calvert | No report | For |
| J.P. Morgan | For | No report |
| Goldman Sachs | No report | For |
| Jackson National funds | For | No report |
| Northern Trust and FlexShares | No report | For |
| Lincoln Financial | No report | For |
| Voya | No report | For |
| Nationwide | No report | For |
| BNY Mellon | No report | For |
| Pacific Life funds | No report | For |
| MFS | No report | For |
| Dodge & Cox | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited meeting?
39 Form N-PX filers reported votes at the meeting of 30 May 2024. One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited with a meeting date within three days of 30 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.